Basel-based biopharmaceutical Versameb has raised 6.4 million Swiss francs in a Seed C financing round and will put the funds towards expanding its technology platform.…
Closing a deal is more art than science. This is especially true in the biopharma industry where investments and partnerships are key elements to success.…